Clinical Trial Update: Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity [Phase 3]

View source ↗

Summary

A Phase 3 comparative trial in healthy adults evaluates reactogenicity and immunogenicity of Hepatyrix versus Havrix with Typherix or Tiphim Vi for Hepatitis A …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Havrix (hepatitis A vaccine)
• Hepatyrix (Hepatitis A vaccine)
• Tiphim Vi (Typhoid vaccine (Vi polysaccharide))
• Typherix (Typhoid vaccine (Vi polysaccharide))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis A | Phase 3 | Status: COMPLETED